Skip to main content
All lobbying filings

ABBOTT LABORATORIES

Lobbying for ABBOTT LABORATORIES

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $1,150,000.00 expenses · posted Jul 20, 2026

Official filing document

 Bills named in this filing 9
  • S 2003
    Strengthening Benefit Plans Act of 2025
  • S 2426
    Equitable Community Access to Pharmacist Services Act
  • HR 3164
    Ensuring Community Access to Pharmacist Services Act
  • S 4118
    Hospice CARE Act of 2026
  • HR 7966
    Hospice CARE Act of 2026
  • S 3387
    Ensuring Safe and Toxic-Free Foods Act of 2023
  • HR 2300
    To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…
  • HR 9817
    Toxic Free Food Act of 2024
  • HR 4958
    GRAS Act
 Lobbying activity 8
Budget/Appropriations

S.2003 The Strengthening Benefit Plans Act of 2025.

Tariff (miscellaneous tariff bills)

Proposals related to The United States-Mexico-Canada Agreement (USMCA). Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations.

Consumer Issues/Safety/Products

Proposals related to data privacy/data collection, usage and retention.

Health Issues

S.2426/H.R.3164 Equitable Community Access to Pharmacist Services Act. S.4118/H.R.7966 The Hospice Care Accountability, Reform and Enforcement Act of 2026. Proposals related to the advancement, testing and detection of Traumatic Brain Injury (TBI). Proposals related to Department of Defense coverage of continuous glucose monitors. Proposals related to digital health technologies and innovations. Proposals related to medical device cybersecurity. Proposals related to colorectal cancer screening. Proposals to support updates to the Veteran colorectal cancer screening directive. Proposals regarding the creation of quality measures for colorectal cancer screening.

Medicare/Medicaid

Proposals related to Medicare coverage of continuous glucose monitors. Proposals related to the National Coverage Determination for colorectal cancer screening. Proposals related to the competitive bidding process. Proposals related to The RAPID (Regulatory Alignment for Predictable and Immediate Device) coverage pathway initiative for eligible Breakthrough Medical Devices.

Trade (domestic/foreign)

Proposals related to U.S. global health programs and pandemic preparedness.

Law Enforcement/Crime/Criminal Justice

Proposals related to third party litigation reform.

Food Industry (safety, labeling, etc.)

S.3387 - Ensuring Safe and Toxic-Free Foods Act of 2023. H.R.2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. H.R.9817 Toxic Free Food Act of 2024. H.R.4958 The Grocery Reform and Safety (GRAS) Act. Proposals related to infant formula ingredients. Proposals related to access to infant formula. Proposals related to oral nutrition supplements usage in hospital care settings.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem